Europe — EMA
Oroxine (Levothyroxine Sodium Pentahydrate)
Levothyroxine sodium pentahydrate, the active ingredient in Oroxine, is a synthetic thyroid hormone presented as a tablet for oral use. It replaces or supplements thyroid hormone in patients with hypothyroidism.
Request sourcing
What is Levothyroxine Sodium Pentahydrate?
Levothyroxine sodium pentahydrate, the active ingredient in Oroxine, is a synthetic thyroid hormone presented as a tablet for oral use. It replaces or supplements thyroid hormone in patients with hypothyroidism. GNH USA supplies Oroxine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Oroxine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Levothyroxine Sodium Pentahydrate used for?
Oroxine is a levothyroxine product that acts on the thyroid hormone pathway to restore normal metabolism.
- Primary hypothyroidism: normalises thyroid hormone levels and alleviates symptoms such as fatigue and weight gain. - Secondary hypothyroidism: provides the missing thyroid hormone when pituitary disease limits TSH production. - Congenital hypothyroidism: ensures adequate thyroid hormone for growth and neurodevelopment in infants. - Thyroid cancer follow‑up care: suppresses TSH to reduce stimulation of residual thyroid tissue after thyroidectomy.
What are the side effects of Levothyroxine Sodium Pentahydrate?
The
